The European medical cannabis sector is experiencing unprecedented growth, driven by progressive legislation, expanding patient access, and a maturing supply chain, according to a new report. Findings from The European Cannabis Report: 10th Edition, published today (Tuesday 29 July), reflect a decade of immense change across European [...]
Older veterans who smoked weed were found to be less likely to experience adverse cardiovascular events, according to a study which claims to be the largest of its kind. This story first appeared on leafie, view here Author: Kevin Dinneen
Current methods used by police to detect drug driving are not based on science, say the authors of a new paper calling for an overhaul of cannabis impairment testing. As cannabis becomes legal in a growing number of US states, public safety experts have raised concerns [...]
The Loop, the UK’s only dedicated drug testing charity, has launched a £25,000 fundraising campaign to expand its harm reduction services. This story first appeared on leafie, view here Author: Liam O'Dowd
In a special edition of the Business of Cannabis Podcast, we go from ‘anecdote to evidence’ with Dr Anne Katrin Schlag, Head of Research and Interim CEO at Drug Science, and Graham Woodward, Chief Operating Officer at Releaf. Together, they explore how the UK can move [...]
Over four years after its slated launch, the NHS Cannabis Patient Registry is set to publish its first data. The years of obfuscation and delay prompted a Freedom of Information request by Business of Cannabis, which has established that the NHS will publish data from its ‘registry’ by the ‘end [...]
By Dr Sue Clenton, Medical Director, Rupa Shah, Chief Legal and Compliance Officer, and Graham Woodward, Chief Operations Officer, Releaf In a healthcare landscape as tightly regulated as the UK’s medical cannabis sector, building a clinical team isn’t just operational work, it’s mission-critical. With the field [...]
A new clinical trial will investigate the potential of cannabis-based treatment to improve quality of care for hospice eligible patients with dementia. The University of Maryland School of Medicine (UMSOM) Palliative Medicine Program has launched a new clinical trial funded by the National Institute on Aging [...]
New research suggests THC-dominant medicinal cannabis provides sustained relief for patients with clinically significant mental health symptoms. This story first appeared on leafie, view here Author: Liam O'Dowd
The study provides preclinical evidence that psilocybin can extend the life of mice and of cells of lab-grown human tissue, which could lead to it being used as a treatment to improve both quality of life and longevity. This story first appeared on leafie, view here [...]
The support group PatientsCann UK has filed a formal complaint against senior police leaders over comments linking the smell of cannabis with criminality and public fear, stating the comments could put patients at risk. This story first appeared on leafie, view here Author: Kevin Dinneen
It’s natural to have questions when considering a new medication, and for many exploring medical cannabis, a common query is about its effects, particularly the feeling often described as a “high.” While cannabis has a long history of medicinal use globally and became legal for medical [...]
Over the past eight months, Business of Cannabis, Cannabis Health, leafie and CannaReporter have conducted a wide-ranging investigation into Dr Green Digital Key — a high-profile blockchain project positioning itself as a game-changer in global cannabis access. Backed and vocally promoted by a man who styles [...]
A bill allowing adults over 21 to possess up to 100 grams of cannabis and grow three plants has been approved by the country’s Senate, and will now be signed by the president to come into law in January 2026. This story first appeared on leafie, [...]
While achieving seizure freedom remains the primary goal of epilepsy treatment, approximately 30% of patients with drug-resistant epilepsy continue to experience seizures despite trying multiple conventional medications. This story first appeared on leafie, view here Author: Kevin Dinneen
Research from two separate studies has highlighted how promotional packaging and social media content can make cannabis-infused products more appealing to teens, prompting calls for more effective regulations. Bright colours, fruit imagery, and labels like “locally made” or “vegan” when used on packaging for cannabis edibles [...]
While frequently disproven, the gateway drug hypothesis claims that cannabis users will go on to use harder, more dangerous substances such as heroin and methamphetamine. This story first appeared on leafie, view here Author: Liam O'Dowd
Patients have called for Switzerland’s new cannabis laws to address ‘unsatisfactory’ medical access ahead of an upcoming consultation on the draft legislation. As legislators look to make further reforms to Switzerland’s cannabis laws, campaigners are urging them to consider the daily realities of those who rely [...]
In the first controlled clinical trial of CBD in boys with autism, two-thirds of participants showed behavioural improvements with treatment, but there was also a significant placebo effect. Researchers at the Center for Medicinal Cannabis Research at University of California San Diego School of Medicine have [...]
The UK’s Food Standards Agency (FSA) has announced some significant updates to its multi-year CBD Novel Foods approvals process, finally offering hundreds of long-suffering businesses some light at the end of the tunnel. Following suggestions from the FSA late last year that it planned to ‘clearly communicate [...]
A brutally honest call-in to the UK medical cannabis patient community, about ego, division, and why we’re our own worst enemy.
The post This Isn’t a Movement, It’s a Mess first appeared on PatientsCann UK.
Copyright © 2020 – 2026 | The Cannabis Pages | All Rights Reserved | Important Notice | The Cannabis Pages “TCP” is an information resource for medical cannabis patients and prescribers. Nothing on the site should be construed as a promotion or inducement. TCP does not promote any product or represent that the products mentioned on TCP’s website are treatment for any kind of medical condition. TCP cannot guarantee that information provided is error-free or complete and is not responsible for the quality of the information provided by users. Cannabis is an unlicensed medication which can only be administered under the supervision of a licensed physician.
